Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02777749 · ClinicalTrials.gov registry record · Phase 4
Adductor Canal Block Versus Periarticular Bupivicaine Injection in Total Knee Arthroplasty
A Phase 4 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 155
- Enrollment target
NCT02777749 is a Phase 4 study that has completed, run by Columbia University. The registered enrollment target is 155 participants.
The verdict
NCT02777749, a Phase 4 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 155 participants
- Enrollment target
Study Summary
The objective of the study is to compare the efficacy of adductor canal blocks versus periarticular bupivacaine injections for pain management in total knee arthroplasty. This randomized clinical trial will compare outcomes between adductor canal blocks, periarticular bupivacaine injections, and periarticular liposomal bupivacaine injections. Results from this study will help determine the most appropriate perioperative pain management strategy for patients undergoing a total knee arthroplasty.
Interventions
- DRUG Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2016-07-19 |
| Est. Completion | 2017-11-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02777749
The ClinicalTrials.gov registry entry for NCT02777749 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bupivacaine is the first listed.
NCT02777749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02777749 about?
NCT02777749 is a clinical study titled "Adductor Canal Block Versus Periarticular Bupivicaine Injection in Total Knee Arthroplasty". The objective of the study is to compare the efficacy of adductor canal blocks versus periarticular bupivacaine injections for pain management in total knee arthroplasty. This randomized clinical trial will compare outcomes between adductor canal blocks, periarticular bupivacaine injections, and per...
What is the current status of trial NCT02777749?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 155 participants. The study started on 2016-07-19. Estimated completion is 2017-11-01.
What interventions are being tested in trial NCT02777749?
The interventions under investigation include: Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT02777749?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.